How has this study helped patients and researchers?

This study helped researchers learn more about how acalabrutinib acts in the blood of healthy participants when given in different ways. Researchers look at the results of many studies to decide which treatments work best and are safest. This summary shows only the main results from this 1 study. Other studies may provide new information or different results. Further clinical studies with acalabrutinib in the treatment of COVID-19 are not planned.